ŠERÝ, Omar, J. JANOUTOVA, Laura EWERLINGOVÁ, Alice HÁLOVÁ, Jan LOCHMAN, Vladimír JANOUT, Naim Akhtar KHAN and VJ BALCAR. CD36 gene polymorphism is associated with Alzheimer's disease. Biochimie. Paris: Elsevier France- editions Scientifiques Medicales Elsevier, 2017, vol. 135, April, p. 46-53. ISSN 0300-9084. Available from: https://dx.doi.org/10.1016/j.biochi.2017.01.009.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name CD36 gene polymorphism is associated with Alzheimer's disease
Authors ŠERÝ, Omar (203 Czech Republic, guarantor, belonging to the institution), J. JANOUTOVA (203 Czech Republic), Laura EWERLINGOVÁ (203 Czech Republic, belonging to the institution), Alice HÁLOVÁ (203 Czech Republic, belonging to the institution), Jan LOCHMAN (203 Czech Republic, belonging to the institution), Vladimír JANOUT (203 Czech Republic, belonging to the institution), Naim Akhtar KHAN (250 France) and VJ BALCAR (203 Czech Republic).
Edition Biochimie, Paris, Elsevier France- editions Scientifiques Medicales Elsevier, 2017, 0300-9084.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher France
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.188
RIV identification code RIV/00216224:14310/17:00095706
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.biochi.2017.01.009
UT WoS 000397694600006
Keywords in English Polymorphism; Association; CD36; Gene; ApoE; MMSE
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 29/3/2018 23:24.
Abstract
CD36 gene encodes a membrane glycoprotein (type B scavenger receptor) present on the surface of many types of cells and having multiple cellular functions ranging from angiogenesis to gustatory perception of fatty acids. Using a case control genetic association approach we have analyzed selected single nucleotide polymorphisms (SNP's) in a total of 859 patients with Alzheimer's disease (AD) and controls and have identified the allele A in rs3211892 polymorphism of CD36 gene as significantly increasing the risk of AD. Additionally we have investigated, in the same sample of control subjects and patients, SNP's in ApoE gene and confirmed that the previously identified AD-associated SNP's indeed increased the risk and decreased the age of onset of AD as reported by others earlier. Based on the current knowledge of CD36 biochemistry we propose that the AD risk-imparting variants of CD36 alter cholesterol homeostasis, oxidation stress or induce pathological inflammatory cascades. The SNP rs3211892 has previously been associated with heart disease and other conditions but the present study is the first to identify a significant association between variations in CD36 gene and the risk of Alzheimer's disease.
Links
NV16-31207A, research and development projectName: Genetika a epidemiologie Alzheimerovy choroby
16-31207A, interní kód MU
(CEP code: NV16-31207A)
Name: Genetika a epidemiologie Alzheimerovy choroby (Acronym: Alzheimer)
Investor: Ministry of Health of the CR
PrintDisplayed: 1/10/2024 05:36